Lv6
2370 积分 2022-08-19 加入
Formulation of Monoclonal Antibody Therapies
16天前
已完结
High-concentration biologic formulations: challenges, strategies, and emerging technologies for subcutaneous delivery
21天前
已完结
An Intercompany Perspective on Compatibility and In-use Stability Studies to Enable Administration Of Biopharmaceutical Drug Products
3个月前
已完结
Current Industry Best Practice on in-use Stability and Compatibility Studies for Biological Products
3个月前
已完结
Colloidal Stability Assessment of a Model Antibody Oligonucleotide Conjugate
3个月前
已完结
Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice
3个月前
已完结
Quantitative Laser Diffraction Mediated Detection of Submicron and Subvisible Aggregates (100 nm–10 μm) in Biotherapeutics: Need for Regulatory Attention To this Neglected Particle Size Range
3个月前
已完结
Modeling Filtration Flow Rate in Peristaltic Pump Systems for High-Viscosity Bovine Serum Albumin: A Multivariate Nonlinear Approach
3个月前
已完结
Engineering the subcutaneous delivery of antibody-drug conjugates
3个月前
已完结
Reaching new heights? Maximum subcutaneous injection volumes from a technical and clinical development strategy perspective
3个月前
已完结
皖公网安备34019202002308
